Flowers Foods, Inc. (NYSE: FLO - Get Free Report) has received a consensus rating of "Reduce" from the six research firms that are covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a sell recommendation and three have issued a hold recommendation on the company. The average 1-year price target among
Flowers Foods (NYSE: FLO - Get Free Report) and Edible Garden (NASDAQ: EDBL - Get Free Report) are both small-cap consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, profitability, analyst recommendations and dividends. Valuation and Earnings This table compares
Flowers Foods, Inc. faces accelerating volume declines and fierce competition, with Q2 results and guidance notably weaker than expected. Despite price increases in branded segments, FLO's revenue and market share declined. Both S&P and Moody's downgraded FLO's debt to junk status, citing persistent category weakness, high leverage, and slow deleveraging.
Flowers Foods, Inc. (NYSE: FLO - Get Free Report) shares hit a new 52-week low during mid-day trading on Monday. The stock traded as low as $5.86 and last traded at $5.9150, with a volume of 13240217 shares changing hands. The stock had previously closed at $5.94. Wall Street Analyst Weigh In A number of
THOMASVILLE, Ga., Aug. 28, 2026 /PRNewswire/ -- Flowers Foods, Inc. (NYSE: FLO) today announced that its board of directors has declared a quarterly dividend of $0.1250 per share, representing the 96th consecutive quarterly dividend paid by the company, which is payable on September 25, 2026, to shareholders of record on September 11, 2026.
DKB survey indicates Gen Z is more aware of organic health benefits than previous generations MILWAUKIE, Ore., Aug. 27, 2026 /PRNewswire/ -- Dave's Killer Bread ® (DKB), the nation's No.
I had previously been bearish on Flowers Foods because the dividend seemed unsustainable. The recent dividend cut addressed that point. Earnings continued to disappoint with Q2 missing expectations and the company trimming full-year guidance. Management expects continued weakness into Q3, but anticipated cost savings and product innovation could stabilize performance in Q4.